Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma

This study has been completed.
Information provided by (Responsible Party):
Genentech, Inc. Identifier:
First received: November 9, 2005
Last updated: November 23, 2011
Last verified: November 2011